On January 12, 2023, Paragon’s Brian Blase, PhD, and Drew Keyes were quoted in Health Care News by the Heartland Institute. From the article titled “White House Renews Emergency Declaration for the 12th Time”:
The Biden Administration’s handling of COVID-19 will dominate much of the debate in the new Congress as Republicans lead the House with a slight majority. Health care reform will also be high on the priority list, but the passage of major health care legislation is unlikely due to the divided partisan control of the House and Senate.
Congress could advance measures to reorganize federal bureaucracies and investigate their actions during the COVID-19 pandemic, says Paragon Health Institute (PHI) President Brian Blase, Ph.D.
“[In the House,] Republicans will chair the committees, and … they will be setting the priorities and conducting oversight,” said Blase, on the Heartland Daily Podcast, on December 23. “I think there will be some areas—hospital consolidation and price transparency—where there will be serious conversations.”
One or more House committees could examine the actions of the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH) during the national health emergency, says Blase.
“I expect them to carry out investigations into the origin of COVID and the failure of CDC, FDA, and NIH during the pandemic,” said Blase.